Literature DB >> 511362

Penetration of ampicillin into urethral and cervical secretions after oral administration of bacampicillin.

L O Kallings, G Eriksson, S Hoffner, U B Linse.   

Abstract

The study comprised 24 male and 24 female patients treated either for uncomplicated gonorrhoea or as a prophylaxis. A single dose of 800 mg of bacampicillin + 1.0 g probenecid was administered orally to each patient. The concentrations of ampicillin in urethra and cervix were assayed by means of alginate swabs that were used as diffusion centres on agar diffusion plates. The inhibition zones were compared with a standard series of swabs containing known amounts of ampicillin. The amounts of secretions absorbed into the swabs were determined by weighing each swab before and after taking the specimen. The median ampicillin concentration in the male urethra one hour after the single dose of bacampicillin plus probenecid was 2.0 micrograms/ml of urethral secretion and increased to 3.2 micrograms/ml two hours after administration of the antibiotic. In the female urethra, the median concentrations of ampicillin were 1.5 micrograms/ml and 2.3 micrograms/ml of urethral secretion one and two hours, respectively, after the same dosage as above. The corresponding ampicillin concentrations in the cervical secretion were 1.6 micrograms/ml and 2.9 micrograms/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511362     DOI: 10.1007/bf01659777

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Absorption of bacampicillin and ampicillin and penetration into body fluids (skin blister fluid, saliva, tears) in healthy volunteers.

Authors:  C Simon; V Malerczyk; M Klaus
Journal:  Scand J Infect Dis Suppl       Date:  1978

2.  A clinical dose-response study of bacampicillin in uncomplicated gonorrhoea.

Authors:  S Bengtsson; G Erikson; L O Kallings; I Moberg; E Sandström; J Wallin; G Wallmark
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  The survival time for different bacteria in various transport media.

Authors:  B Gästrin; L O Kallings; A Marcetic
Journal:  Acta Pathol Microbiol Scand       Date:  1968

5.  Penicillin treatment in oral surgery in patients with coagulation disorders.

Authors:  C Lundberg; C E Nord; G Ramström
Journal:  Int J Oral Surg       Date:  1975-10

6.  Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin.

Authors:  J Sjövall; L Magni; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

7.  Effect of bacampicillin on human mouth, throat and colon flora.

Authors:  A Heimdahl; C E Nord; K Weilander
Journal:  Infection       Date:  1979       Impact factor: 3.553

  7 in total
  3 in total

Review 1.  Pharmacokinetics of bacampicillin tablets in adults.

Authors:  W A Craig
Journal:  Bull N Y Acad Med       Date:  1983-06

Review 2.  Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.

Authors:  T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 3.  The aminopenicillins: development and comparative properties.

Authors:  D S Reeves; D W Bullock
Journal:  Infection       Date:  1979       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.